普洛药业：CDMO业务已成为公司业绩增长的主要引擎

Core Viewpoint - The company emphasizes that its stock price is influenced by various factors including macroeconomic environment, policy landscape, industry cycles, and operational performance, leading to a relatively stable stock price recently [1] Group 1: Strategic Initiatives - The company is accelerating its strategic transformation and upgrading efforts while continuously strengthening its core competitiveness [1] - The CDMO (Contract Development and Manufacturing Organization) business is experiencing sustained growth and has become the highest gross margin segment for the company, serving as a major driver for performance improvement [1] Group 2: Shareholder Returns - The company places significant importance on shareholder returns, consistently implementing cash dividends and share buybacks to enhance shareholder value [1] - The company aims to genuinely allow investors to share in the growth and success of the company [1]